Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.
Identifieur interne : 006009 ( Main/Exploration ); précédent : 006008; suivant : 006010Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.
Auteurs : P. Brantus [France]Source :
- Annals of tropical medicine and parasitology [ 1364-8594 ] ; 2009.
Descripteurs français
- KwdFr :
- MESH :
- pathogénicité : Wuchereria bancrofti.
- usage thérapeutique : Filaricides.
- Animaux, Femelle, Filariose lymphatique, Humains, Interactions hôte-parasite, Lymphoedème, Mâle, Santé mondiale.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Filaricides.
- complications : Elephantiasis, Filarial.
- pathogenicity : Wuchereria bancrofti.
- therapy : Elephantiasis, Filarial, Lymphedema.
- Animals, Female, Global Health, Host-Parasite Interactions, Humans, Male.
Abstract
The aim of the Global Programme to Eliminate Lymphatic Filariasis is to eradicate one of the world's leading causes of permanent and long-term disability, at least as a public-health problem. The achievement of this goal is based on the interruption of the transmission of the causative parasites (so preventing new cases) and, as a 'second pillar', the prevention of disability in those who are infected. The disability is associated with the main clinical manifestations of human infection with Wuchereria or Brugia spp. (i.e. hydrocele, lymphoedema and/or 'acute attacks'). The World Health Organization and its partners have established strategies and activities both for managing lymphoedema, through community home-based care, and for increasing access to surgery for hydrocele. Over the last decade, there has been progress made in preventing the disability of lymphatic filariasis, the monitoring and evaluation of such disability and its control, and the integration of disability prevention with mass drug administrations and efforts to control other disabling diseases. That progress and the challenges that remain in the prevention of the morbidity and disability attributable to lymphatic filariasis are here reviewed.
DOI: 10.1179/000349809X12502035776432
PubMed: 19843392
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002C89
- to stream PubMed, to step Curation: 002C89
- to stream PubMed, to step Checkpoint: 002C89
- to stream Ncbi, to step Merge: 003684
- to stream Ncbi, to step Curation: 003684
- to stream Ncbi, to step Checkpoint: 003684
- to stream Main, to step Merge: 006081
- to stream Main, to step Curation: 006009
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.</title><author><name sortKey="Brantus, P" sort="Brantus, P" uniqKey="Brantus P" first="P" last="Brantus">P. Brantus</name><affiliation wicri:level="3"><nlm:affiliation>Neglected Tropical Diseases, Health and Rehabilitation Unit, Handicap International France, 14 Avenue Berthelot, 69361 Lyon Cedex 07, France. brantus.pierre@orange.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neglected Tropical Diseases, Health and Rehabilitation Unit, Handicap International France, 14 Avenue Berthelot, 69361 Lyon Cedex 07</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="RBID">pubmed:19843392</idno><idno type="pmid">19843392</idno><idno type="doi">10.1179/000349809X12502035776432</idno><idno type="wicri:Area/PubMed/Corpus">002C89</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C89</idno><idno type="wicri:Area/PubMed/Curation">002C89</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C89</idno><idno type="wicri:Area/PubMed/Checkpoint">002C89</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002C89</idno><idno type="wicri:Area/Ncbi/Merge">003684</idno><idno type="wicri:Area/Ncbi/Curation">003684</idno><idno type="wicri:Area/Ncbi/Checkpoint">003684</idno><idno type="wicri:Area/Main/Merge">006081</idno><idno type="wicri:Area/Main/Curation">006009</idno><idno type="wicri:Area/Main/Exploration">006009</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.</title><author><name sortKey="Brantus, P" sort="Brantus, P" uniqKey="Brantus P" first="P" last="Brantus">P. Brantus</name><affiliation wicri:level="3"><nlm:affiliation>Neglected Tropical Diseases, Health and Rehabilitation Unit, Handicap International France, 14 Avenue Berthelot, 69361 Lyon Cedex 07, France. brantus.pierre@orange.fr</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Neglected Tropical Diseases, Health and Rehabilitation Unit, Handicap International France, 14 Avenue Berthelot, 69361 Lyon Cedex 07</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation></author></analytic><series><title level="j">Annals of tropical medicine and parasitology</title><idno type="eISSN">1364-8594</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Elephantiasis, Filarial (complications)</term><term>Elephantiasis, Filarial (therapy)</term><term>Female</term><term>Filaricides (therapeutic use)</term><term>Global Health</term><term>Host-Parasite Interactions</term><term>Humans</term><term>Lymphedema (therapy)</term><term>Male</term><term>Wuchereria bancrofti (pathogenicity)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Femelle</term><term>Filaricides (usage thérapeutique)</term><term>Filariose lymphatique ()</term><term>Humains</term><term>Interactions hôte-parasite</term><term>Lymphoedème ()</term><term>Mâle</term><term>Santé mondiale</term><term>Wuchereria bancrofti (pathogénicité)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Filaricides</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Elephantiasis, Filarial</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Wuchereria bancrofti</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Filaricides</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Global Health</term><term>Host-Parasite Interactions</term><term>Humans</term><term>Male</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Femelle</term><term>Filariose lymphatique</term><term>Humains</term><term>Interactions hôte-parasite</term><term>Lymphoedème</term><term>Mâle</term><term>Santé mondiale</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The aim of the Global Programme to Eliminate Lymphatic Filariasis is to eradicate one of the world's leading causes of permanent and long-term disability, at least as a public-health problem. The achievement of this goal is based on the interruption of the transmission of the causative parasites (so preventing new cases) and, as a 'second pillar', the prevention of disability in those who are infected. The disability is associated with the main clinical manifestations of human infection with Wuchereria or Brugia spp. (i.e. hydrocele, lymphoedema and/or 'acute attacks'). The World Health Organization and its partners have established strategies and activities both for managing lymphoedema, through community home-based care, and for increasing access to surgery for hydrocele. Over the last decade, there has been progress made in preventing the disability of lymphatic filariasis, the monitoring and evaluation of such disability and its control, and the integration of disability prevention with mass drug administrations and efforts to control other disabling diseases. That progress and the challenges that remain in the prevention of the morbidity and disability attributable to lymphatic filariasis are here reviewed.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Auvergne-Rhône-Alpes</li><li>Rhône-Alpes</li></region><settlement><li>Lyon</li></settlement></list><tree><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Brantus, P" sort="Brantus, P" uniqKey="Brantus P" first="P" last="Brantus">P. Brantus</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006009 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006009 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19843392
|texte= Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19843392" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |